Description

Merit Medical Systems: An Insight Into Its Product Innovation & Clinical Advancements!

Merit Medical Systems reported robust financial performance in the fourth quarter of 2024, displaying notable revenue and profit growth. The company recorded total revenue of $355.2 million for Q4, reflecting a 9% increase year-over-year on a GAAP basis and 10% on a constant currency basis. This exceeded Merit Medical’s growth expectations, which it had projected at 6% to 9%. The growth was primarily driven by strong performances in the Cardiovascular segment, which grew by 8%, and the Endoscopy segment, which saw an 88% increase. Excluding the revenue from recent acquisitions, the organic constant currency growth was 6.1% and 6.5% for the Cardiovascular and Endoscopy segments, respectively.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!